NEW YORK (GenomeWeb News) – A researcher at the Huntsman Cancer Institute at the University of Utah has received a $1.5 million grant from the National Cancer Institute to use a mouse model to study genetic mutations that may be involved in the origin and growth of melanoma.

University of Utah Health Sciences said on Monday that Matt VanBrocklin, an associate professor in the university's Department of Surgery, will use the award to investigate the role of the c-KIT gene in melanoma, and in particular a type of melanoma caused by chronic sun damage.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.